home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/ac20a614-7a6a-41c2-8ce4-5dbd77bcbb4b_v03p0074.pdf
whitepaper
SHARESHARESHARE
CURRENT THERAPEUTIC TARGETS FOR ALZHEIMER’S DISEASE
Alzheimer’s disease (AD) is one of the most common multifactorial diseases, including a range of abnormal cellular/molecular processes occurring in different regions of the brain. This disease is considered to be a major contributor to dementia in elderly people. The pathophysiology involves the accumulation of extracellular plaques containing the β-amyloid protein which is generated by the breakdown of the β-amyloid precursor protein (APP) in the brain. DOWNLOAD